These days, Biotherapeutics are the rapidly growing group of pharmaceuticals, actually for a treatment option, a variety of chronic and sometimes life-threatening conditions. Those represent a dissimilar group of biological preparations that widely encompasses nucleic acids, proteins, whole cells, viral particles, and vaccines.
In recent years, great progress has been made regarding the development of safe and effective Biotherapeutics, and in the adoption of cost-effective, more efficient, and modernized manufacturing processes. This trend looks forward to accelerating in the forthcoming years, as emerging fields related to advanced therapies or personalized medicine mature.
Advances in Drug Discovery and Development
Any Procedure which is applied to drug discovery and development by the medical community and pharmaceutical industry has a direct change in the further availability of better, innovative, and therapeutic treatment for patients with cancer. Drug discovery is defined as a complicated learning technique whereby research efforts are directed towards discover and assimilating new innovative thoughts to produce a drug to provide a benefit to a patient population.
Subsequently, a highly useful technology or approach to drug discovery should give both effective thoughts and the applications of newly discovered observations that can be utilized for therapeutic benefit.
Title : Interdependent antioxidant therapy in covid-19 and other critical diseases
Richard Z. Cheng, Cheng Integrative Health Center, United States
Title : Biotechnological exploration of phyto-drugs against MDR bacteria targeting DNA topoisomerase I and RNA polymerase
Asit Kumar Chakraborty, Vidyasagar University, India
Title : New excipient to formulate poorly soluble APIs
Rajendran Arunagiri, Eastman, United States
Title : Limiting factors in implementing pharmacovigilance principles in the elderly
Hana Hassan, University of Bristol, United Kingdom
Title : Intellection of molecular drug delivery models -an ayurvedic perspective
Ashtavaidyan Dr. E.T. Krishnan Mooss, Vaidyaratnam Group , India
Title : Evaluation of the wound healing activity of Hyoscyamus nigar seed powder on the wistar albino rats
Jeevanath Ruban, Trincomalee Campus, Sri Lanka
Title : Comparison of dexmedetomidine and propofol with ketofol in sedation of candidates for cataract surgery
Alireza Kamali, Arak University of Medical Sciences, Iran (Islamic Republic of)
Title : Multi-detection of pharmaceutical contamination in environment
Andreia Freitas, INIAV and REQUIMTE, Portugal
Title : Exosome-like nanoparticles from plants: Promising pharmaceutical preparations and delivery carriers
Chongzhi Liu, The First Affiliated Hospital of Chengdu Medical College, China